← back to search

Masaki Saito

Nagoya City University · JP
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Liver Disease Diagnosis and Treatment, and Hepatitis C virus research.
h-index
47
citations
7,765
works
417
NIH funding
primary concept
email

Recent publications

The development of a methodology to measure primary ciliary length in neural progenitor cells with a target molecule knocked down
Biochemistry and Biophysics Reports 2026cited by 0position: contributordoi
Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets.
2023cited by 10position: contributordoi
MAST4 promotes primary ciliary resorption through phosphorylation of Tctex-1.
2023cited by 5position: contributordoi
Recent Progress on Genetically Modified Animal Models for Membrane Skeletal Proteins: The 4.1 and MPP Families.
2023cited by 2position: contributordoi
Cytoskeletal Protein 4.1G Is Essential for the Primary Ciliogenesis and Osteoblast Differentiation in Bone Formation.
2022cited by 7position: contributordoi
Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
2022cited by 7position: contributordoi
Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG<sub>2a</sub>-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells.
2021cited by 21position: contributordoi
Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method.
2021cited by 15position: contributordoi
An Anti-HER2 Monoclonal Antibody H<sub>2</sub>Mab-41 Exerts Antitumor Activities in Mouse Xenograft Model Using Dog HER2-Overexpressed Cells.
2021cited by 11position: contributordoi
Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors.
2021cited by 9position: contributordoi
Development of a Novel Anti-HER2 Monoclonal Antibody H<sub>2</sub>Mab-181 for Gastric Cancer.
2021cited by 7position: contributordoi
Tctex-1 augments G protein-coupled receptor-mediated G<sub>s</sub> signaling by activating adenylyl cyclase.
2021cited by 1position: contributordoi
Activity of Adenylyl Cyclase Type 6 Is Suppressed by Direct Binding of the Cytoskeletal Protein 4.1G.
2019cited by 6position: contributordoi
[Mechanisms of cell proliferation through primary cilium].
2019cited by 0position: contributordoi
[Unlabeled imaging of primary cilia by scanning ion conductance microscopy].
2019cited by 0position: contributordoi
[Current situation of researches on a sensor organelle, primary cilium, to understand the pathogenesis of ciliopathy].
2019cited by 0position: contributordoi
Tctex‐1 controls ciliary resorption by regulating branched actin polymerization and endocytosis
EMBO Reports 2017cited by 56position: firstdoi
IGF-1 Activates a Cilium-Localized Noncanonical Gβγ Signaling Pathway that Regulates Cell-Cycle Progression
Developmental Cell 2013cited by 104position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2021–2026)Ching‐Hwa Sung · Cornell University2 papers (2013–2017)Jen-Zen Chuang · Cornell University2 papers (2013–2017)Aiqun Li · Binzhou Medical University1 papers (2013–2013)Yukinari Kato · Japan Agency for Medical Research and Development1 papers (2021–2021)Manabu Kawada · Microbial Chemistry Research Foundation1 papers (2021–2021)Takeharu Sakamoto · Springer Nature1 papers (2023–2023) · 1 papers (2023–2023)Wataru Otsu · Gifu Pharmaceutical University1 papers (2026–2026)Guanjie Li · Tohoku University1 papers (2021–2021)Yu Mori · Tohoku University1 papers (2022–2022)Tomokazu Ohishi · Microbial Chemistry Research Foundation1 papers (2021–2021)Nobuo Terada · Shinshu University1 papers (2022–2022)Takahiro Yoshizawa · Shinshu University1 papers (2023–2023)Takeya Sato · Elsevier, Inc.1 papers (2023–2023)Yasufumi Takahashi · Japan Science and Technology Agency1 papers (2019–2019) · 1 papers (2013–2013) · 1 papers (2017–2017)Celine Yeh · Memorial Sloan Kettering Cancer Center1 papers (2013–2013) · 1 papers (2017–2017)